Equities research analysts expect Physicians Realty Trust (NYSE:DOC) to post $95.26 million in sales for the current quarter, according to Zacks. Six analysts have provided estimates for Physicians Realty Trust’s earnings, with the highest sales estimate coming in at $98.20 million and the lowest estimate coming in at $90.63 million. Physicians Realty Trust posted sales of $73.67 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 29.3%. The business is expected to report its next quarterly earnings report before the market opens on Wednesday, February 28th.
On average, analysts expect that Physicians Realty Trust will report full-year sales of $95.26 million for the current year, with estimates ranging from $330.70 million to $344.50 million. For the next fiscal year, analysts expect that the firm will post sales of $412.63 million per share, with estimates ranging from $363.62 million to $445.15 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Physicians Realty Trust.
Several equities research analysts recently commented on DOC shares. Zacks Investment Research lowered Physicians Realty Trust from a “hold” rating to a “sell” rating in a research report on Tuesday, January 30th. Raymond James Financial set a $20.00 target price on Physicians Realty Trust and gave the company a “buy” rating in a research report on Thursday, December 7th. B. Riley restated a “buy” rating on shares of Physicians Realty Trust in a research report on Wednesday, November 1st. Royal Bank of Canada restated a “buy” rating and set a $21.00 target price on shares of Physicians Realty Trust in a research report on Wednesday, November 15th. Finally, SunTrust Banks set a $18.00 price target on Physicians Realty Trust and gave the stock a “hold” rating in a research note on Monday, January 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $20.05.
Shares of Physicians Realty Trust (NYSE DOC) opened at $15.05 on Friday. Physicians Realty Trust has a 52-week low of $14.76 and a 52-week high of $21.85. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.59 and a current ratio of 1.59. The company has a market capitalization of $2,657.81, a PE ratio of 14.12, a P/E/G ratio of 2.28 and a beta of 0.41.
In other news, Director Tommy G. Thompson purchased 2,705 shares of the company’s stock in a transaction that occurred on Thursday, December 14th. The shares were acquired at an average cost of $18.46 per share, with a total value of $49,934.30. Following the purchase, the director now owns 49,339 shares in the company, valued at $910,797.94. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.51% of the stock is currently owned by corporate insiders.
Several institutional investors have recently modified their holdings of the company. Ameritas Investment Partners Inc. raised its stake in shares of Physicians Realty Trust by 4.3% in the second quarter. Ameritas Investment Partners Inc. now owns 13,543 shares of the real estate investment trust’s stock worth $273,000 after purchasing an additional 554 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its stake in shares of Physicians Realty Trust by 13.1% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 25,922 shares of the real estate investment trust’s stock worth $460,000 after purchasing an additional 3,000 shares during the last quarter. US Bancorp DE raised its stake in shares of Physicians Realty Trust by 5.6% in the fourth quarter. US Bancorp DE now owns 59,473 shares of the real estate investment trust’s stock worth $1,070,000 after purchasing an additional 3,149 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in shares of Physicians Realty Trust by 6.7% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 58,036 shares of the real estate investment trust’s stock worth $1,044,000 after purchasing an additional 3,647 shares during the last quarter. Finally, Amalgamated Bank raised its stake in shares of Physicians Realty Trust by 19.8% in the third quarter. Amalgamated Bank now owns 22,708 shares of the real estate investment trust’s stock worth $403,000 after purchasing an additional 3,757 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/23/95-26-million-in-sales-expected-for-physicians-realty-trust-doc-this-quarter.html.
Physicians Realty Trust Company Profile
Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
Get a free copy of the Zacks research report on Physicians Realty Trust (DOC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.